Dr. Amelia Scott Barrett, MD, and Dr. Judy Lane, MD, explore the landscape of migraine treatments, starting with an in-depth discussion on sumatriptan, triptans, and CGRP treatments. They then delve into the administration and efficacy of monoclonal antibodies, offering insights into their role in migraine management. The episode introduces gepants, a newer class of medications, and examines their speed and response rates, providing listeners with a comprehensive overview of contemporary therapeutic options for migraine relief.
Migraines often have hidden causes like nutrient deficiencies, toxins, or hormonal imbalances. Find out what might be affecting you at https://theheadachequiz.com.
(0:00) Sumatriptan, Triptans, and CGRP Treatments
(1:18) Monoclonal Antibodies: Administration and Efficacy
(3:02) Introduction and Insights on Gepants
(6:57) Speed and Response Rates of Gepants